Variant report
Variant | nsv980058 |
---|---|
Chromosome Location | chr3:61355685-61361013 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs200768524 | chr3:61355713-61355714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113139255 | chr3:61355714-61355715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527592874 | chr3:61355737-61355738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143358086 | chr3:61355743-61355744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201755790 | chr3:61355744-61355745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200285536 | chr3:61355746-61355747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150621394 | chr3:61355752-61355753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376643239 | chr3:61355753-61355754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114707909 | chr3:61355769-61355770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570313838 | chr3:61355775-61355776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs186845711 | chr3:61355786-61355787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75761448 | chr3:61355816-61355817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568109678 | chr3:61355835-61355836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535511811 | chr3:61355851-61355852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144268525 | chr3:61355858-61355859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201188088 | chr3:61355886-61355887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571001864 | chr3:61355896-61355897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs540160454 | chr3:61355901-61355902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191683853 | chr3:61355915-61355916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73837529 | chr3:61355930-61355931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140087904 | chr3:61355953-61355954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs79494554 | chr3:61355957-61355958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373030982 | chr3:61355977-61355978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574082168 | chr3:61356014-61356015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143725929 | chr3:61356021-61356022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559341862 | chr3:61356083-61356084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146841588 | chr3:61356085-61356086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552061657 | chr3:61356153-61356154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564263363 | chr3:61356173-61356174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531630484 | chr3:61356175-61356176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369956788 | chr3:61356194-61356195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549737739 | chr3:61356195-61356196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183127443 | chr3:61356249-61356250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs13061149 | chr3:61356250-61356251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs376276654 | chr3:61356290-61356291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140684745 | chr3:61356370-61356371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565683557 | chr3:61356389-61356390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539401122 | chr3:61356422-61356423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186552395 | chr3:61356439-61356440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144501084 | chr3:61356479-61356480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576712636 | chr3:61356553-61356554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34569215 | chr3:61356661-61356662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537729595 | chr3:61356667-61356668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs571605372 | chr3:61356669-61356670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs151116681 | chr3:61356680-61356681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574147104 | chr3:61356682-61356683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538800926 | chr3:61356692-61356693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541128357 | chr3:61356708-61356709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553006815 | chr3:61356888-61356889 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577704856 | chr3:61356889-61356890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Mental retardation | 17847001 | CNVD |
Neuroticism | 17667963 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 22102821 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:61345600-61356800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr3:61350200-61359400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr3:61356400-61357000 | Enhancers | Fetal Kidney | kidney |
4 | chr3:61356800-61357000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr3:61357000-61358400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr3:61358400-61358600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |